Freedom of Information request on education materials for Exjade on eMC
Published 28 May 2021
28th April 2021 FOI 21/314 Dear
We can confirm that the education materials for Exjade on eMC are the most recent approved versions however we are aware that they are subject to change. Please note, in line with GVP Module XVI, generic companies are encouraged to contact the MAH for the innovator to request their aRMM.
Kind regards,
Pharmacovigilance Service Team Vigilance and Risk Management of Medicines Division Medicines and Healthcare Products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14 4PU